Nu Skin Enterprises (NYSE:NUS) Price Target Cut to $12.50 by Analysts at DA Davidson

Nu Skin Enterprises (NYSE:NUS - Get Free Report) had its target price dropped by equities research analysts at DA Davidson from $15.50 to $12.50 in a report released on Thursday, Benzinga reports. The firm presently has a "neutral" rating on the stock. DA Davidson's price objective suggests a potential downside of 2.19% from the company's current price.

Separately, StockNews.com downgraded Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Saturday, February 24th. Four investment analysts have rated the stock with a hold rating, According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $20.83.

Nu Skin Enterprises Trading Up 2.9 %

NYSE NUS traded up $0.36 on Thursday, hitting $12.78. The company's stock had a trading volume of 758,837 shares, compared to its average volume of 729,770. Nu Skin Enterprises has a 52-week low of $11.73 and a 52-week high of $38.23. The firm has a market cap of $631.59 million, a P/E ratio of 70.56 and a beta of 1.13. The company's 50-day simple moving average is $12.66 and its 200 day simple moving average is $15.89. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Wednesday, May 8th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.04. The firm had revenue of $417.31 million for the quarter, compared to the consensus estimate of $426.55 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The business's revenue for the quarter was down 13.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.37 EPS. Research analysts predict that Nu Skin Enterprises will post 1.13 EPS for the current fiscal year.

Institutional Investors Weigh In On Nu Skin Enterprises

Several institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC purchased a new position in shares of Nu Skin Enterprises during the fourth quarter valued at $33,000. CWM LLC boosted its position in Nu Skin Enterprises by 38.4% in the first quarter. CWM LLC now owns 3,286 shares of the company's stock valued at $45,000 after buying an additional 911 shares during the last quarter. Signaturefd LLC boosted its position in Nu Skin Enterprises by 240.7% in the third quarter. Signaturefd LLC now owns 3,996 shares of the company's stock valued at $85,000 after buying an additional 2,823 shares during the last quarter. Fidelis Capital Partners LLC acquired a new position in Nu Skin Enterprises in the first quarter valued at approximately $112,000. Finally, New Mexico Educational Retirement Board acquired a new position in Nu Skin Enterprises in the first quarter valued at approximately $145,000. 82.84% of the stock is owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.